Product Code: ETC13335719 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market was valued at USD 121 Billion in 2024 and is expected to reach USD 175 Billion by 2031, growing at a compound annual growth rate of 5.60% during the forecast period (2025-2031).
The global Non Steroidal Anti-Inflammatory Drugs (NSAIDs) market is experiencing steady growth driven by factors such as the increasing prevalence of chronic inflammatory diseases, rising geriatric population, and growing awareness about the benefits of NSAIDs in managing pain and inflammation. The market is characterized by the presence of key players offering a wide range of products targeting various therapeutic areas. Advancements in drug delivery technologies and the introduction of novel formulations are also contributing to market expansion. However, concerns regarding the side effects associated with NSAIDs, such as gastrointestinal complications and cardiovascular risks, pose a challenge to market growth. Despite these challenges, the market is expected to witness further growth due to the rising demand for pain management solutions globally.
The Global Non Steroidal Anti Inflammatory Drugs (NSAIDs) market is experiencing significant growth due to the rising prevalence of chronic inflammatory conditions such as arthritis, increasing geriatric population, and the growing demand for over-the-counter pain relief medications. Key trends in the market include the development of novel formulations for targeted drug delivery and the introduction of combination therapies to enhance efficacy. Moreover, the market is seeing opportunities in expanding applications beyond pain management, such as in cancer treatment and cardiovascular diseases. With the increasing focus on personalized medicine and advancements in biotechnology, there is a growing potential for the development of more efficient and safer NSAIDs. Overall, the Global NSAIDs market is poised for continued growth and innovation in the coming years.
The Global Non Steroidal Anti-Inflammatory Drugs (NSAIDs) Market faces several challenges, including the growing concerns over the side effects associated with long-term use of NSAIDs such as gastrointestinal complications and cardiovascular risks. Additionally, increasing competition from alternative pain management therapies and the availability of generic versions of NSAIDs are impacting market growth. Regulatory hurdles related to drug approvals and patent expirations are also significant challenges faced by key players in the market. Furthermore, the rising trend of self-medication practices and the preference for natural remedies among consumers pose additional obstacles for the growth of the Global NSAIDs Market. Overall, navigating these challenges requires companies to focus on innovation, safety, and regulatory compliance to maintain a competitive edge in the market.
The Global Non Steroidal Anti-Inflammatory Drugs (NSAIDs) Market is primarily driven by the increasing prevalence of chronic inflammatory diseases such as arthritis, growing geriatric population, and rising demand for over-the-counter pain relief medications. Additionally, the expanding use of NSAIDs in the treatment of various conditions such as fever, menstrual pain, and migraines is fueling market growth. Furthermore, the introduction of advanced drug delivery systems and formulations, as well as the continuous research and development activities in the field of NSAIDs, are contributing to market expansion. The market is also influenced by factors such as increasing healthcare expenditure, improving access to healthcare services in developing regions, and the growing awareness about the benefits of NSAIDs in pain management.
Government policies related to the Global Non Steroidal Anti Inflammatory Drugs (NSAIDs) market primarily focus on regulating the manufacturing, distribution, and marketing of these drugs to ensure their safety, efficacy, and quality. Regulatory bodies such as the FDA in the United States, the EMA in Europe, and other national regulatory authorities set guidelines for the approval, labeling, and monitoring of NSAIDs to protect public health. These policies also address issues such as over-the-counter availability, prescription requirements, drug interactions, and adverse effects. Additionally, governments may implement pricing and reimbursement policies to control healthcare costs associated with NSAID usage and promote access to essential medications. Overall, government policies play a critical role in shaping the NSAIDs market landscape and safeguarding consumer welfare.
The Global Non Steroidal Anti-Inflammatory Drugs (NSAIDs) market is expected to witness steady growth in the coming years due to the increasing prevalence of conditions such as arthritis, menstrual pain, and migraines. The market is also being driven by the rising geriatric population globally and the growing demand for over-the-counter pain relief medication. Additionally, the introduction of innovative drug formulations and the expanding use of NSAIDs in emerging economies are anticipated to contribute to market growth. However, factors such as the potential side effects associated with NSAIDs and the availability of alternative therapies may pose challenges to market expansion. Overall, the Global NSAIDs market is projected to experience moderate growth in the foreseeable future, with opportunities for market players to focus on research and development efforts to address safety concerns and meet the evolving needs of consumers.
In the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market, Asia is expected to witness significant growth due to the rising prevalence of chronic diseases and increasing healthcare expenditure. North America is projected to dominate the market share, driven by the high adoption rate of NSAIDs, advanced healthcare infrastructure, and strong presence of key market players. In Europe, the market growth is attributed to the increasing geriatric population and rising awareness about the benefits of NSAIDs in pain management. The Middle East and Africa region is anticipated to experience moderate growth, influenced by improving healthcare access and infrastructure development. Latin America is expected to show steady growth due to the expanding pharmaceutical industry and increasing government initiatives to improve healthcare services.
Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, 2021 & 2031F |
3.3 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market - Industry Life Cycle |
3.4 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market - Porter's Five Forces |
3.5 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market Trends |
6 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market, 2021 - 2031 |
6.1 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By OTC NSAIDs, 2021 - 2031 |
6.1.3 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Prescription NSAIDs, 2021 - 2031 |
6.1.4 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Topical NSAIDs, 2021 - 2031 |
6.1.5 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Ibuprofen, 2021 - 2031 |
6.2.3 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Celecoxib, 2021 - 2031 |
6.2.4 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Diclofenac Gel, 2021 - 2031 |
6.2.5 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Naproxen, 2021 - 2031 |
6.3 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Pharmacies, 2021 - 2031 |
6.3.3 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.4 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.3.5 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.4 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Application, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Pain Relief, 2021 - 2031 |
6.4.3 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Arthritis Treatment, 2021 - 2031 |
6.4.4 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Musculoskeletal Pain, 2021 - 2031 |
6.4.5 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Fever Reduction, 2021 - 2031 |
7 North America Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Overview & Analysis |
7.1 North America Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, 2021 - 2031 |
7.2 North America Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 North America Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.5 North America Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6 North America Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Application, 2021 - 2031 |
8 Latin America (LATAM) Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Overview & Analysis |
8.1 Latin America (LATAM) Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Type, 2021 - 2031 |
8.4 Latin America (LATAM) Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
8.5 Latin America (LATAM) Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By End User, 2021 - 2031 |
8.6 Latin America (LATAM) Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Application, 2021 - 2031 |
9 Asia Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Overview & Analysis |
9.1 Asia Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Type, 2021 - 2031 |
9.4 Asia Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
9.5 Asia Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By End User, 2021 - 2031 |
9.6 Asia Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Application, 2021 - 2031 |
10 Africa Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Overview & Analysis |
10.1 Africa Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Type, 2021 - 2031 |
10.4 Africa Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
10.5 Africa Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By End User, 2021 - 2031 |
10.6 Africa Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Application, 2021 - 2031 |
11 Europe Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Overview & Analysis |
11.1 Europe Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Type, 2021 - 2031 |
11.4 Europe Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
11.5 Europe Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By End User, 2021 - 2031 |
11.6 Europe Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Application, 2021 - 2031 |
12 Middle East Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Overview & Analysis |
12.1 Middle East Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Type, 2021 - 2031 |
12.4 Middle East Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
12.5 Middle East Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By End User, 2021 - 2031 |
12.6 Middle East Non Steroidal Anti Inflammatory Drugs NSAIDs Market, Revenues & Volume, By Application, 2021 - 2031 |
13 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market Key Performance Indicators |
14 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market - Export/Import By Countries Assessment |
15 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market - Opportunity Assessment |
15.1 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market Opportunity Assessment, By Type, 2021 & 2031F |
15.3 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
15.4 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market Opportunity Assessment, By End User, 2021 & 2031F |
15.5 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market Opportunity Assessment, By Application, 2021 & 2031F |
16 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market - Competitive Landscape |
16.1 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenue Share, By Companies, 2024 |
16.2 Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |